Renal Cell Carcinoma (RCC) (Phase ll Only)
1 clinical trials · Condition
◉ Watch Renal Cell Carcinoma (RCC) (Phase ll Only)
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation and Cohort Expansion Study of Anti-CD27 (Varlilumab) and Anti-PD-1 (Nivolumab) in Advanced Refractory Solid Tumors (NCT02335918) | Celldex Therapeutics | 2015-01-01 |
Track Renal Cell Carcinoma (RCC) (Phase ll Only) automatically
Every clearance here is in the API, with alerts when new ones post.